Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baclofen for GERD with Incomplete PPI Response
NCT03835442Completed
- Sponsor
- UZ Leuven
- Start
- Jan 2010
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of baclofen in gastroesophageal reflux disease (GERD), sponsored by UZ Leuven. Primary endpoint: Reflux Questionnaire at 4 weeks. Started Jan 2010; status: completed.
02
Drugs
baclofen
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT03835442.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03835442.